XENPOZYME
NDC 58468-0050, olipudase alfa-rpcp, injection, powder, lyophilized, for solution, from Genzyme Corporation.
- Product NDC
- 58468-0050
- Status
- Listed
- Labeler
- Genzyme Corporation
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761261
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLIPUDASE ALFA20 mg/5.1mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58468-0050-1 | 58468005001 | 1 VIAL in 1 CARTON (58468-0050-1) / 5.1 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/01a910ee-a33e-4be3-ac41-322d64c34311Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=58468-0050
Use it
Look up 58468-0050 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58468-0050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.